Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
From January 22 to March 1, 2001
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2001
Report date:
2001

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
Version / remarks:
1996
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
1992
GLP compliance:
yes (incl. QA statement)
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
Data from a GPMT method was available

Test material

Constituent 1
Reference substance name:
Yellow 981
IUPAC Name:
Yellow 981
Test material form:
solid: particulate/powder

In vivo test system

Test animals

Species:
guinea pig
Strain:
Himalayan
Remarks:
Himalayan spotted: lbm: GOHI; SPF-quality guinea pigs
Sex:
female

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
water
Remarks:
bi-distilled
Concentration / amount:
20 %
Day(s)/duration:
day 1
Adequacy of induction:
highest technically applicable concentration used
Route:
epicutaneous, occlusive
Vehicle:
water
Remarks:
bi-distilled
Concentration / amount:
50 %
Day(s)/duration:
day 8 / 48 h
Adequacy of induction:
highest technically applicable concentration used
Challenge
No.:
#1
Route:
epicutaneous, occlusive
Vehicle:
water
Remarks:
bi-distilled
Concentration / amount:
10 %
Day(s)/duration:
day 22 / 24 h
Adequacy of challenge:
highest non-irritant concentration
No. of animals per dose:
15 female animals (10 treatment + 5 negative control)
Details on study design:
- Day 1: 6 × 8 cm region clipped from scapular region, and three pairs of intradermal injections (0.1 ml per site) were given to each animal (1st pair: 1:1 (v/v) mixture of Freund's Complete Adjuvant (FCA) and physiological saline; 2nd pair: 20 % test item in bi-distilled water; 3rd pair: 20 % test item 50 % FCA).
- Day 8: same area was re-clipped and a 2 × 4 cm patch of filter paper saturated with 0.3 ml of test item (50 % test item in bi-distilled water) was placed over the injection sites. The patch was covered with aluminum foil and firmly secured by an elastic plaster wrapped around the trunk of the animal and secured with impervious adhesive tape for 48 hours.
- Day 10: occlusive dressings were removed.
- Day 11: site assessed for erythema and oedema (24 h after removal).
- Day 12: site assessed for erythema and oedema (48 h after removal).
- Day 22: 3 × 3 cm filter paper saturated with 10 % test item in bi-distilled water was applied to the left, clipped flank of each animal for 24 h, and covered in the same way as stated above; additionally, the right flank of each animal was treated with bi-distilled water in the same way as the left.
- Day 23: dressings were removed 24 hours after application.
- Day 24: flanks were depilated (21 h after removal) and scored for erythema and oedema (24 h after removal).
- Day 25: flanks were scored for erythema and oedema (48 h after removal).
Challenge controls:
- Intradermal induction: water in place of test item
- Epidermal induction: water in place of test item
- Epidermal challenge: same as treatment group
Positive control substance(s):
yes
Remarks:
2-mercaptobenzothiazole (intradermal induction: 5 %; epidermal induction: 15 %; challenge: 1 %)

Results and discussion

Positive control results:
Sensitisation rate after 24 and 48 hours: 100 %

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
0 %
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
no indication of skin sensitisation
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
0 %
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
no indication of skin sensitisation
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
10 %
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
no indication of skin sensitisation
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
10 %
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
no indication of skin sensitisation
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
0 %
No. with + reactions:
0
Total no. in group:
5
Reading:
1st reading
Hours after challenge:
48
Group:
negative control
Dose level:
0 %
No. with + reactions:
0
Total no. in group:
5
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
10 %
No. with + reactions:
0
Total no. in group:
5
Remarks on result:
no indication of skin sensitisation
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
10 %
No. with + reactions:
0
Total no. in group:
5
Remarks on result:
no indication of skin sensitisation
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
1 % 2-mercaptobenzothiazole
No. with + reactions:
10
Total no. in group:
10
Remarks on result:
positive indication of skin sensitisation
Reading:
1st reading
Hours after challenge:
48
Group:
positive control
Dose level:
1 % 2-mercaptobenzothiazole
No. with + reactions:
10
Total no. in group:
10
Remarks on result:
positive indication of skin sensitisation

Applicant's summary and conclusion

Interpretation of results:
other: not classified according to the CLP Regulation (EC 1272/2008)
Conclusions:
Sensitisation rate: 0 %, thus, the substance is not a skin sensitiser.